C M Grosse

Alfentanil and Placebo Analgesia

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult

Effects of ethylene glycol and metabolites on in vitro development of rat embryos during organogenesis

Anesthesiology

IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans

Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings

Remifentanil

Pharmacokinetics of Opioids in Liver Disease

Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil

Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness

Prediction of difficult tracheal intubation

Mode of Action: Oxalate Crystal-Induced Renal Tubule Degeneration and Glycolic Acid-Induced Dysmorphogenesis—Renal and Developmental Effects of Ethylene Glycol

Intracranial Pressure and Hemodynamic Effects of Remifentanil Versus Alfentanil in Patients Undergoing Supratentorial Craniotomy

Clinical Pharmacology of Tramadol

Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications

Automated Covariate Model Building Within NONMEM

IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans

A Multicenter Evaluation of Total Intravenous Anesthesia with Remifentanil and Propofol for Elective Inpatient Surgery

Dose-dependent transitions in mechanisms of toxicity: case studies

Pharmacokinetics Anesthesiologists, and Pharmacodynamics of Remifentanil in Persons with Renal Failure Compared with Healthy Volunteers

Predicting Difficult Intubation in Apparently Normal Patients

Dose-dependent transitions in mechanisms of toxicity

Safety and Feasibility of Continuous Infusion of Remifentanil in the Neurosurgical Intensive Care Unit

Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.

Preliminary Pharmacokinetics and Pharmacodynamics of an Ultra-Short-Acting Opioid

Pharmacokinetics of ethylene glycol II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1® mice*

Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.

Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using a deuterated internal standard

PHARMACOKINETIC COMPARISON OF GI87084B, A NOVEL ULTRA-SHORT ACTING OPIOID, AND ALFENTANIL